Skip to main content
Displaying 25 - 36 of 54
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy